
Entheon Biomedical Partners with Divergence Neuro Technologies Inc. for Predictive Biomarker Platform Development
Vancouver, British Columbia–(Newsfile Corp. – January 19, 2021) – Entheon Biomedical Corp. (CSE: ENBI) (FSE: 1XU1) (OTC Pink: ENTBF) (“Entheon” or the “Company“), a biotechnology company focused on developing psychedelic medicines to treat addiction, announced […]